M
Microvitality develops novel capsule technology for precise, non-invasive sampling of the small intestine microbiome. This fluid biopsy approach yields uncontaminated data essential for advancing microbiome research and biomarker discovery. The technology supports pharmaceutical development, diagnostics, and precision medicine by providing crucial insights into host-microbiome interactions.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- Microvitality develops novel capsule technology for precise, non-invasive sampling of the small intestine microbiome. This fluid biopsy approach yields uncontaminated data essential for advancing microbiome research and biomarker discovery. The technology supports pharmaceutical development, diagnostics, and precision medicine by providing access to this previously underexplored gut region.